Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers

Clinical trial NCT06689436 · COMPLETED

Trial details

NCT number: NCT06689436
Sponsor: TAHO Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Random Allocation Intermittent Fasting Enteral Feeding

Start date: 2024-11-16
Primary completion: 2025-01-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.